Dune Medical Devices Ltd.

www.dunemedical.com

Now Dillon Medical Technologies

High-Tech Company

Acquired by Dilon Technologies

Graduated from: Trendlines Incubators

TECH VERTICALS

Healthtech, Medical Devices, MedTech

General Data

Sector	Medical Devices
Company Stage:	Revenue Growth
Established	2001
Number of Employees	40
Employees in Israel	25
Reg. Number:	abCDe

DESCRIPTION

Dune Medical Devices was founded to realize the extraordinary medical potential of its proprietary tissue characterization technology. Offering surgeons and radiologists the ability to detect cancer in real time, this technology holds promise for a broad range of diagnostic and therapeutic applications. The company's first offering, the MarginProbe® System, is FDA approved (PMA), being used routinely to deliver real-time assessment of the tumor margins during breast cancer surgery. To date, the device has been used in over 15000 commercial procedures. Multiple studies have shown that use of the device leads to more than a 50% reduction in reoperations. In development, supported by a Horizon 2020 grant, a soft tissue smart biopsy system, which incorporates the tissue characterization technology, with first indication is breast tissue. Dune Medical Devices is a privately held company with offices in the US and Israel.

TECHNOLOGY

Real-time, RF spectroscopy for tissue characterization.

Products and Phases

Product	Phase
MarginProbe®	FDA Approved CE Approved
The Dune MarginProbe System comprises a sterile handheld probe and portable console. When the probe tip is applied to an excised lumpectomy segment, RF signals are transmitted into the tissue and reflected back to the console, where they are analyzed using a specialized algorithm to determine tissue status.

	TARGET MARKETS
	Hospitals, Medical Institutions, Surgeons, Radiologists

	BUSINESS MODEL
	B2C

SERVICE PROVIDERS

Company Name	Type
abC Defghij	Law Firm

CONTACT INFO

Expand / Collapse All

Main Address: Caesarea, Israel

Address	20 Alon Hatavor St., Caesarea Industrial Park
POB	3131
City	Caesarea
Country	Israel
Zip	3088900

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

Branch Address: Alpharetta, United States

Address	6120 Windward Parkway, Suite 160
City	Alpharetta
State/Province	GA
Country	United States
Zip	30005

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Ms. Lori Chmura	CEO
Ms. Susan Turner	VP, Healthcare Economics & Reimbursement
Mr. Avihai Lachman	VP, R&D
Dr. Dan Hashimshony	Founder	X-Technologies (CTO)
Ms. Nurit Ninio-Sade	Office Manager

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Venture Partner, Apax Partners
abC Defghij	Board Member	CEO, Dune Medical
abC Defghij	Board Member	Adviser, Canepa U.S
abC Defghij	Board Member	Adviser, Canepa U.S
abC Defghij	Board Member	Former CEO, Dune Medical Devices
abC Defghij	Board Member	Adviser, The Kraft Group

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Apr. 02, 2020

Revenue Growth

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Fourth Round

Jun. 01, 2017

Revenue Growth

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Private Investor	abCDe

Third Round

Jun. 26, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Private Equity Fund	abCDe
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Holding Company	abCDe
abC Defghij	Investment Company	abCDe

Second Round

Jun. 28, 2006

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Equity Fund	abCDe	Led the round
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

First Round

Mar. 29, 2004

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Private Equity Fund	abCDe	Led the round
abC Defghij	Angel Club/ Group	abCDe
abC Defghij	Investment Company	abCDe
abC Defghij	Private Investor	abCDe

Seed

Dec. 01, 2001

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe	R&D Grant
abC Defghij	Incubator	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Aug. 22, 2016

Revenue Growth

abCDe

By EASME - EU Executive Agency for SMEs.

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-Lateral R&D Program	abCDe

Last Updated:	abCDe
IVC Number:	abCDe